Latest From This Author
Orchid Health dice que su prueba puede identificar los embriones con menor probabilidad de desarrollar cáncer, esquizofrenia y otras enfermedades. Pero la ciencia y la ética son motivo de preocupación.
-
Orchid Health tells would-be parents its test can identify embryos with the lowest likelihood of developing cancer, schizophrenia and other diseases. But there are concerns about both the science and the ethics.
-
The U.S. has rescinded its pause on the use of Johnson & Johnson’s COVID-19 vaccine, clearing the way for states to resume using it.
-
Some Latino parents fear for their lives as Los Angeles public schools reopen. If they get COVID-19, they wonder, who will care for their children?
-
California’s coronavirus case rate is now the lowest in the continental U.S., and the second-lowest in the nation.
-
With its emphasis on live performance, the School of Rock had to adapt during the pandemic. But soon its L.A. students can head back to the classroom.
-
Officials have said they don’t plan to issue COVID-19 vaccine “passports.” That didn’t stop them from giving businesses an incentive to require them.
-
What does it mean to “do no harm”? That’s what the experts who advised the CDC on Johnson & Johnson’s COVID-19 vaccine had to consider.
-
L.A. County has made big strides in administering vaccines in underserved communities, but they still lag far behind wealthier areas.
-
With vaccinations rolling out and film and TV production heating up, there’s a growing sense in Hollywood that things are finally on the mend.
